CLOSE
Social Media links WEBSITE OF THE STATE OF SOUTH DAKOTA DEPARTMENT OF HEALTH
Doneen Hollingsworth, Secretary of Health

South Dakota Board of Pharmacy

Newsletter


January 2013
South Dakota State Board of Pharmacy
3701 West 49th Street - Suite 204, Sioux Falls, SD 57106
 

NEW REGISTERED PHARMACISTS
     The following candidates recently met licensure requirements and were registered as pharmacists in South Dakota:  Nicholas Hite, Bonnie Walno, Sarah Luettel, Cynthia Way, Erica Zimprich, Stacey Block, Kam Cheon Li, Sean Harms, Jill Streiff, Karen Finck, Charly Abraham, Jeri Costel, and Audra Olson.        

NEW PHARMACIES
      Pharmacy licenses have been issued recently to:  Lewis Family Drug #73 – Chamberlain; James Bregel PIC.

BOARD STAFF

Rita Schulz has joined the Board Staff as Sr. Secretary. Rita comes to our office from the South Dakota State University College of Pharmacy. Rita has vast experience in many levels of state government and will be a definite asset to our team. She began her duties with the staff on October 31st 2012. Rita’s primary responsibilities will include office administration oversight, student affiliations, as well as assist with grant fund writing.

Ronald Huether has fully made the transition to retirement. Kari Shanard-Koenders has assumed all of the Prescription Drug Monitoring Program director responsibilities.    

MEDICATION REQUESTS FOR “OFFICE USE”
The board receives frequent advice from pharmacists related to prescription the pharmacy may receive from a prescriber indicating the “for office use” on the prescription. SDCL 36-11-2 (22) defines this. “Prescription drug order,” a written or oral order of a practitioner for a drug or drug device for a specific patient. Therefore, a prescription that is not patient specific is not valid. If a practitioner requests medication from a pharmacy, this transaction is considered a wholesale distribution. For non-controlled substances, the invoice must contain the name, strength, and dosage form of the medication, date of the transaction, name and address of the seller and the purchaser. For controlled substances, the record must contain all the information stated above, as well as the DEA numbers of the both the seller and the purchaser. If the medication is a CII controlled substance, the purchaser must execute a DEA Form 222 to the seller prior to the transaction. Records for controlled substance transaction must be maintained in a readily retrievable manner for a minimum of 2 years.  

STAFF NOTES
 As a result of the tragic events that occurred with the New England Compounding Center Pharmacy in Framingham, Massachusetts; it is imperative that anyone compounding Sterile Products should review their policies and procedures as it relates to the USP 797 document and ARSD 20:51:31 (Sterile Compounding Practices).  The Board encourages you to print off the current version of USP 797. USP is making the document available on a temporary basis by going to this link:  http://www.usp.org/usp-healthcare-professionals/compounding/compounding-general-chapters/download-usp-nf-general-chapter-pharmaceutical-compoundingIf you are outsourcing sterile compounded products, the Board would suggest that you visit the ASHP website (www.ashp.org) to review their Sterile Compounding Resource Center.  They provide guidelines on outsourcing sterile compounding services. It is essential for the safety of all patients that all the pharmacies that compound medications, regardless of setting, adhere to the very highest standards. 

PRESCRIPTION DRUG MONITORING PROGRAM (PDMP) UPDATE

The PDMP is progressing well and we continue to receive positive comments on the program from prescribers, dispensers and law enforcement.  Nearly half (43%) of South Dakota practicing pharmacists (486) have been granted on-line access to the PDMP database while approximately 21%  (655) of all prescribers have been approved. Pharmacists’ efforts to reach prescribers they interact with to assist with PDMP education and registration have been extremely helpful.  New data on the 2011 National Survey on Drug Use in Health (NSDUH) is available at http://www.samhsa.gov/.  This link provides excellent statistics on Prescription Drug Abuse in the country. As of November 20, 2012 there are over 1.35 million prescriptions in the database. We are planning a South Dakota PDMP Advisory Council meeting for January 15, 2012.  All comments are appreciated. 

Top 10 Controlled Substances in South Dakota by Number of Doses Dispensed:  January 1, 2012 to November 20, 2012.

2012 Most Prescribed Drugs

RX's

Quantity

Quant/Rx

Hydrocodone/APAP

254,069

14,303,045

56

Zolpidem

88,632

2,831,632

32

Lorazepam

74,352

3,509,306

47

Clonazepam

64,692

3,988,649

62

Alprazolam

50,805

2,944,954

58

Methylphenidate

43,778

1,982,267

45

Amphetamine Salts

40,072

1,789,340

45

Oxycodone/APAP

38,836

2,372,450

61

Oxycodone

36,825

3,038,785

83

APAP/Codeine

32,384

1,277,104

39

 

Pharmacists are encouraged to use information from the SDPDMP when dispensing controlled drug prescriptions to patients.  You may register for on-line access by going to the following website – www.hidinc.com/sdpmp

Please call the Board office if you have any questions about this very important program. 

 

BOARD MEETING DATES

              Please check our website for the time, location and agenda for future Board meetings.  

            

BOARD OF PHARMACY STAFF DIRECTORY

Office Phone    605-362-2737 FAX    605-362-2738
Randy Jones, Executive Director randy.jones@state.sd.us
Kari Shanard-Koenders, PDMP Director kari.shanard-koenders@state.sd.us
Gary Karel, Pharmacy Inspector     gary.karel@state.sd.us
Paula Stotz, Pharmacy Inspector     paula.stotz@state.sd.us
Jill Vanderbush, Sr. Secretary    jill.vanderbush@state.sd.us
Melanie Houg, Secretary       melanie.houg@state.sd.us
Jony Bruns, PDMP Assistant jony.bruns@state.sd.us 
Board of  Pharmacy Website  www.pharmacy.sd.gov

 

Please read all Newsletters and keep them for future reference.  The Newsletters will be used in hearings as proof of notification. Please contact the Board office at 605-362-2737 if you have questions about an article in the Newsletter. Past Newsletters are also available on the Board’s website.